People
Stephanie Monaghan O’Brien
Stephanie Monaghan O’Brien has been a member of the Morningside investment team since 1997. Her work includes operational guidance and financing for science and technology companies. Vigeo identifies her Harvard undergraduate and NYU law degrees; the Catholic Community Fund explicitly identifies her current investment-professional affiliation with Morningside Technology Advisory LLC. Existing Apellis role is preserved.
Roles
Apellis Pharmaceuticals
CurrentDirector (reported in the annual report published in 2025)
Morningside Ventures
CurrentInvestment Professional; Counsel (Technology Advisory affiliation)